Copyright
©The Author(s) 2019.
World J Clin Oncol. Feb 24, 2019; 10(2): 86-97
Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.86
Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.86
Variable | Overall survival1 | Progression free survival2 | ||||||||
All patients (n = 247) | MA-noTBI (n = 38) | MA + TBI (n = 51) | RIC-noTBI (n = 118) | RIC + TBI (n = 40) | All patients (n = 247) | MA-noTBI (n = 38) | MA + TBI (n = 51) | RIC-noTBI (n = 118) | RIC + TBI (n = 40) | |
CD3+ cell dose | ||||||||||
< Median HR | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
> Median HR | 1.1 | 1.0 | 0.5 | 1.3 | 0.8 | 1.0 | 1.1 | 0.4 | 1.4 | 0.6 |
95%CI | 0.8-1.5 | 0.4-2.6 | 0.2-1.1 | 0.8-2.1 | 0.3-2.2 | 0.7-1.4 | 0.4-2.6 | 0.2-1.0 | 0.8-2.2 | 0.2-1.7 |
P | NS | NS | NS | NS | NS | NS | NS | 0.05 | NS | NS |
CD4+ cell dose | ||||||||||
< Median HR | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
> Median HR | 1.2 | 1.1 | 0.6 | 1.2 | 2.0 | 1.1 | 1.1 | 0.5 | 0.3 | 1.5 |
95%CI | 0.8-1.7 | 0.4-2.6 | 0.2-1.3 | 0.8-1.0 | 0.7-6.0 | 0.8-1.6 | 0.5-2.6 | 0.2-1.2 | 0.8-2.1 | 0.5-4.3 |
P | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
CD8+ cell dose | ||||||||||
< Median HR | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
> Median HR | 1.2 | 1.5 | 1.0 | 1.3 | 0.5 | 1.1 | 1.1 | 0.9 | 1.2 | 0.7 |
95%CI | 0.8-1.6 | 0.5-4.2 | 0.4-2.3 | 0.8-2.1 | 0.2-1.8 | 0.8-1.5 | 0.5-2.8 | 0.4-2.0 | 0.8-2.0 | 0.2-2.0 |
P | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
TNC dose | ||||||||||
< Median HR | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
> Median HR | 0.8 | 1.0 | 0.7 | 0.9 | 0.2 | 0.8 | 1.1 | 0.7 | 1.1 | 0.2 |
95%CI | 0.6-1.2 | 0.4-2.4 | 0.3-1.9 | 0.5-1.5 | 0.1-0.8 | 0.6-1.2 | 0.4-2.5 | 0.3-1.6 | 0.6-1.8 | 0.1-0.8 |
P | NS | NS | NS | NS | 0.02 | NS | NS | NS | NS | 0.02 |
CD34+ cell dose | ||||||||||
< 4 × 106/kg HR | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
4-8 × 106/kg HR | 1.0 | 0.5 | 1.3 | 1.1 | 0.6 | 0.8 | 0.7 | 1.2 | 1.0 | 0.6 |
95%CI | 0.6-1.5 | 0.2-1.4 | 0.4-4.4 | 0.6-1.9 | 0.1-2.3 | 0.6-1.4 | 0.2-2.1 | 0.4-4.0 | 0.6-1.8 | 0.2-2.6 |
P | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
> 8 × 106/kg HR | 1.0 | 1.3 | 0.7 | 1.1 | 0.5 | 0.9 | 1.5 | 0.6 | 1.1 | 0.5 |
95%CI | 0.6-1.5 | 0.4-4.0 | 0.2-2.3 | 0.5-2.0 | 0.1-2.4 | 0.6-1.4 | 0.5-4.6 | 0.2-2.0 | 0.6-2.0 | 0.1-2.6 |
P | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
- Citation: Burns M, Singh AK, Hoefer CC, Zhang Y, Wallace PK, Chen GL, Platek A, Winslow TB, Iovoli AJ, Choi C, Ross M, McCarthy PL, Hahn T. Impact of conditioning regimen on peripheral blood hematopoietic cell transplant. World J Clin Oncol 2019; 10(2): 86-97
- URL: https://www.wjgnet.com/2218-4333/full/v10/i2/86.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i2.86